2024, Número 4
Análisis crítico del ensayo RESHAPE-HF2: sesgos y limitaciones que deben tenerse en cuenta antes de incorporarlo a las próximas guías clínicas
Idioma: Ingles.
Referencias bibliográficas: 8
Paginas: 115-117
Archivo PDF: 229.96 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(6):589-90. doi: 10.1093/ehjci/jew025.
Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: A report from the American Society of Echocardiography Developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2019;32(4):431-475. doi: 10.1016/j.echo.2019.01.003.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063.
Bao J, Kan R, Chen J, Xuan H, Wang C, Li D, et al. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials. Pharmacol Res. 2021;169:105573. doi: 10.1016/j.phrs.2021.105573.